Galderma's full year 2024 results

This year has been marked by incredible achievements for Galdema, with record net sales of 4.410 billion USD, key approvals and the global launch of groundbreaking innovations. Hear CEO Flemming Ørnskov, M.D., MPH discuss our company’s financial performance, steady growth across key dermatology categories, international progress, regulatory milestones, and our outlook for continued success in 2025. Learn more about Galderma’s full-year financial results here: https://www.galderma.com/news/galderm...